The Association of Innovative Pharmaceutical Industry (AIFP) shares the EFPIA’s view expressed in its input into this Inception Impact Assessment. Further to this, we would like to stress some of our main concerns and observations. The European citizens expect to have equal access to safe, state-of-the-art and affordable innovative and established therapies.
AIP
The Association of Innovative Pharmaceutical Industry
Industry association · Czechia
not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts — staff, costs, accreditations — are not available for it.
3
positions filed
in the 583 files tracked
3
legislative files
of 583 tracked
0
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Track The in PolicySpeak: request access →
Work at The Association of Innovative Pharmaceutical Industry? so we know who speaks for it.
Their record over time
The Association of Innovative Pharmaceutical Industry filed 3 positions between 6 Jan 2021 and 27 Apr 2021, across 3 of the 583 legislative files tracked here.
What they argued
The Association of Innovative Pharmaceutical Industry (AIFP) shares the EFPIA’s view expressed in its input into this Inception Impact Assessment. Further to this, we would like to stress some of our main concerns and observations.
The Association of Innovative Pharmaceutical Industry (AIFP) shares the EFPIA´s view expressed in its input into this Inception Impact Assessment. Further to this we would like to stress some of our main concerns and observations.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put The Association of Innovative Pharmaceutical Industry next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
Showing 5 of 85.
Is this your organization?
Everything on this page comes from The Association of Innovative Pharmaceutical Industry’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.